Citations

Clear

1053 citation(s) found for "Andre, F".

Tissue-Nonspecific Alkaline Phosphatase Is Required for MC3T3 Osteoblast–Mediated Protection of Acute Myeloid Leukemia Cells from Apoptosis
Sterner, Rosalie M. , Kremer, Kimberly N. , Dudakovic, Amel , Wijnen, André J. van , Hedin, Karen E. , van Wijnen, Andre J , Westendorf, Jennifer J.

Mayo Clinic

The Journal of Immunology | June 18, 2018 | Volume: 201 | Issue: 3 | Pages: 1086-1096

10.4049/jimmunol.1800174 | PMID 29914885 Get It

Abstract The bone marrow microenvironment harbors and protects leukemic cells from apoptosis-inducing agents via mechanisms that are incompletely understood. We previously showed SDF-1 (CXCL-12), a chemokine readily abundant within the bone marrow microenvironment, induces apoptosis in acute myeloid leukemia (AML) cells that express high levels of the SDF-1 receptor CXCR4. However, differentiating osteoblasts found within this niche protect cocultured AML cells from apoptosis. Additionally, this protection was abrogated upon treatment of the differentiating osteoblasts with histone deacetylase inhibitors (HDACi). In this study, we begin to characterize and target the molecular mechanisms that mediate this osteoblast protection. Quantitative RT-PCR revealed that HDACi treatment of differentiating osteoblasts (mouse MC3T3 osteoblast cell line) reduced expression of multiple genes required for osteoblast differentiation, including genes important for producing mineralized bone matrix. Interestingly, pretreating differentiating osteoblasts with cyclosporine A, a drug known to inhibit osteoblast differentiation, similarly impaired osteoblast-mediated protection of cocultured AML cells (KG1a and U937 human AML cell lines). Both HDACi and cyclosporine A reduced osteoblast expression of the key mineralization enzyme tissue-nonspecific alkaline phosphatase (TNAP; encoded by Alpl). Moreover, specifically reducing TNAP expression or activity in differentiating osteoblasts significantly impaired the ability of the osteoblasts to protect cocultured AML cells. Together, our results indicate that inhibiting osteoblast matrix mineralization by specifically targeting TNAP is sufficient to significantly impair osteoblast-mediated protection of AML cells. Therefore, designing combination therapies that additionally target the osteoblast-produced mineralized bone matrix may improve treatment of AML by reducing the protection of leukemic cells within the bone marrow microenvironment.
Joint contracture is reduced by intra‐articular implantation of rosiglitazone‐loaded hydrogels in a rabbit model of arthrofibrosis
Arsoy, Diren , Salib, Christopher G. , Trousdale, William H. , Tibbo, Meagan E. , Limberg, Afton K. , Lewallen, Eric A. , Reina, Nicolas , Yaszemski, Michael J. , Berry, Daniel J., Wijnen, André J. van , Berry, Daniel J. , Viste, Anthony , Reina, Nicolas , Sanchez-Sotelo, Joaquin, van Wijnen, Andre J , Berry, Daniel J , Berry, Daniel J., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , Abdel, Matthew P.

Mayo Clinic

Journal of Orthopaedic Research | June 14, 2018 | Volume: 36 | Issue: 11 | Pages: 2949-2955

10.1002/jor.24068 | PMID 29901247 Get It

ABSTRACTTrauma, surgery, and other inflammatory conditions can lead to debilitating joint contractures. Adjunct pharmacologic modalities may permit clinical prevention and treatment of recalcitrant joint contractures. We investigated the therapeutic potential of rosiglitazone by intra‐articular delivery via oligo[poly(ethylene glycol)fumarate] (OPF) hydrogels in an established rabbit model of arthrofibrosis. OPF hydrogels loaded with rosiglitazone were characterized for drug elution properties upon soaking in minimum essential media (MEM) with 10% fetal bovine serum and measurements of drug concentrations via High Performance Liquid Chromatography (HPLC). Drug‐loaded scaffolds were surgically implanted into 24 skeletally mature female New Zealand White rabbits that were divided into equal groups receiving OPF hydrogels loaded with rosiglitazone (1.67 mg), or vehicle control (10 µl DMSO). After 8 weeks of joint immobilization, rabbits were allowed unrestricted cage activity for 16 weeks. Contracture angles of rabbit limbs treated with rosiglitazone showed statistically significant improvements in flexion compared to control animals (mean angles, respectively, 64.4° vs. 53.3°, p < 0.03). At time of sacrifice (week 24), animals in the rosiglitazone group continued to exhibit less joint contracture than controls (119.0° vs. 99.5°, p = 0.014). The intra‐articular delivery of rosiglitazone using implanted OPF hydrogels decreases flexion contractures in a rabbit model of arthrofibrosis without causing adverse effects (e.g., gross inflammation or arthritis). Statement of Clinical Significance: Post‐traumatic joint contractures are common and debilitating, with limited available treatment options. Pharmacologic interventions can potentially prevent and treat such contractures. This study is translational in that a commercially approved medication has been repurposed through a novel delivery device. © 2018 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:2949–2955, 2018.
A Simple Dynamic Strategy to Deliver Stem Cells to Decellularized Nerve Allografts
Rbia, Nadia , Bulstra, Liselotte F. , Wijnen, André J. van , van Wijnen, Andre J , Bishop, Allen T. , Shin, Alexander Y.

Mayo Clinic

Plastic & Reconstructive Surgery | June 10, 2018 | Volume: 142 | Issue: 2 | Pages: 402-413

10.1097/prs.0000000000004614 | PMID 29889737 Get It

Background: The addition of adipose-derived mesenchymal stromal cells to decellularized nerve allografts may improve outcomes of nerve reconstruction. Prior techniques used for cell seeding are traumatic to both the mesenchymal stromal cells and nerve graft. An adequate, reliable, and validated cell seeding technique is an essential step for evaluating the translational utility of mesenchymal stromal cell–enhanced decellularized nerve grafts. The purpose of this study was to develop a simple seeding strategy with an optimal seeding duration. Methods: A dynamic bioreactor was used to seed rat and human mesenchymal stromal cells separately onto rat and human decellularized nerve allografts. Cell viability was evaluated by MTS assays and cellular topology after seeding was determined by scanning electron microscopy. Cell density and distribution were determined by Live/Dead assays and Hoechst staining at four different time points (6, 12, 24, and 72 hours). The validity and reliability of the seeding method were calculated. Results: Cells remained viable at all time points, and mesenchymal stromal cells exhibited exponential growth in the first 12 hours of seeding. Seeding efficiency increased significantly from 79.5 percent at 6 hours to 89.2 percent after 12 hours of seeding (p = 0.004). Both intrarater reliability (r = 0.97) and interrater reliability (r = 0.92) of the technique were high. Conclusions: This study describes and validates a new method of effectively seeding decellularized nerve allografts with mesenchymal stromal cells. This method is reproducible, distributes cells homogenously over the graft, and does not traumatize the intraneural architecture of the allograft. Use of this validated seeding technique will permit critical comparison of graft outcomes.
Validation of Osteogenic Properties of Cytochalasin D by High-Resolution RNA-Sequencing in Mesenchymal Stem Cells Derived from Bone Marrow and Adipose Tissues
Samsonraj, Rebekah M. , Paradise, Christopher R. , Dudakovic, Amel , Sen, Buer , Nair, Asha, Dietz, Allan B. , Deyle, David R. , Cool, Simon M. , Rubin, Janet, Wijnen, André J. van , Nair, Asha A, van Wijnen, Andre J , Dietz, Allan B , van Wijnen, Andre J

Mayo Clinic

Stem Cells and Development | June 8, 2018 | Volume: 27 | Issue: 16 | Pages: 1136-1145

10.1089/scd.2018.0037 | PMID 29882479 Get It

Cytotoxic Effects of Nonionic Iodinated Contrast Agent on Human Adipose‐Derived Mesenchymal Stem Cells
Wu, Tao , Nie, Hai , Dietz, Allan B. , Šálek, David, Smith, Jay , Wijnen, André J. van , Qu, Wenchun , Salek, David R, van Wijnen, Andre J , Dietz, Allan B

Mayo Clinic

PM&R | June 1, 2018 | Volume: 11 | Issue: 1 | Pages: 45-55

10.1016/j.pmrj.2018.05.022 | PMID 29860023 Get It

BackgroundTransplantation of mesenchymal stem cells (MSCs) is a promising therapy for degenerative spine conditions. However, cell therapy for painful spine degeneration presently requires use of contrast agents during fluoroscopy‐guided injections, and the effects of these agents on MSCs represents a gap in knowledge.ObjectiveTo investigate the biological effects of contrast media (CM) that are coinjected with MSCs.DesignProspective observational study.SettingAcademic medical center.ParticipantsPatient‐derived clinical‐grade culture expanded MSCs.InterventionsIohexol (Omnipaque300) was reduced to 12.5%, 25%, 50%, and 100% of the stock solution and incubated with MSCs for 30 minutes, 4 hours, and 48 hours. We also used complete media and 12.5%, 25%, 50%, 100% of phosphate‐buffered saline as a control group.Main Outcome MeasuresWe examined cytotoxicity of iohexol at different concentrations and exposure duration, as well as the potential for recovery over time. Cell counts, mitochondrial activity, and quantitative real time reverse‐transcriptase polymerase chain reaction of related genes were analyzed immediately after exposure (day 0) and after 2 days of exposure (day 2).ResultsHuman MSCs exhibit a time‐ and concentration‐dependent cytotoxic response to iodinated CM. A brief, 30‐minute exposure did not affect MSCs function and viability. However, extended treatment with iohexol for 4 hours at 50% or higher concentration had a significant impact on both viability and gene expression in MSCs.ConclusionsIohexol is cytotoxic to MSCs in a time‐and concentration‐dependent manner. Hence, the concentration of CM that accompanies MSC injections should be carefully considered during MSC therapy for disk‐degenerative diseases.Level of EvidenceIII.
150-μm Spatial Resolution Using Photon-Counting Detector Computed Tomography Technology
Rajendran, Kishore , Gong, Hao , Zhou, Wei , Halaweish, Ahmed F., Henning, André , Kappler, S. , Baer, Matthias , Rajendran, Kishore , Zhou, Wei , Leng, Shuai , Fletcher, Joel G. , McCollough, Cynthia H.

Mayo Clinic

Investigative Radiology | May 31, 2018 | Volume: 53 | Issue: 11 | Pages: 655-662

10.1097/rli.0000000000000488 | PMID 29847412 Get It

Objective The aims of this study were to quantitatively assess two new scan modes on a photon-counting detector computed tomography system, each designed to maximize spatial resolution, and to qualitatively demonstrate potential clinical impact using patient data. Materials and Methods This Health Insurance Portability Act–compliant study was approved by our institutional review board. Two high–spatial-resolution scan modes (Sharp and UHR) were evaluated using phantoms to quantify spatial resolution and image noise, and results were compared with the standard mode (Macro). Patients were scanned using a conventional energy-integrating detector scanner and the photon-counting detector scanner using the same radiation dose. In first patient images, anatomic details were qualitatively evaluated to demonstrate potential clinical impact. Results Sharp and UHR modes had a 69% and 87% improvement in in-plane spatial resolution, respectively, compared with Macro mode (10% modulation-translation-function values of 16.05, 17.69, and 9.48 lp/cm, respectively). The cutoff spatial frequency of the UHR mode (32.4 lp/cm) corresponded to a limiting spatial resolution of 150 μm. The full-width-at-half-maximum values of the section sensitivity profiles were 0.41, 0.44, and 0.67 mm for the thinnest image thickness for each mode (0.25, 0.25, and 0.5 mm, respectively). At the same in-plane spatial resolution, Sharp and UHR images had up to 15% lower noise than Macro images. Patient images acquired in Sharp mode demonstrated better delineation of fine anatomic structures compared with Macro mode images. Conclusions Phantom studies demonstrated superior resolution and noise properties for the Sharp and UHR modes relative to the standard Macro mode and patient images demonstrated the potential benefit of these scan modes for clinical practice.
Higher order genomic organization and regulatory compartmentalization for cell cycle control at the G1/S‐phase transition
Ghule, Prachi N. , Seward, David J. , Fritz, Andrew J. , Wijnen, André J. van , Lian, Jane B. , Stein, Janet L. , Stein, Gary S., van Wijnen, Andre J , Boyd, Joseph R.

Mayo Clinic

Journal of Cellular Physiology | May 10, 2018 | Volume: 233 | Issue: 10 | Pages: 6406-6413

10.1002/jcp.26741 | PMID 29744889 Get It

Fidelity of histone gene regulation, and ultimately of histone protein biosynthesis, is obligatory for packaging of newly replicated DNA into chromatin. Control of histone gene expression within the 3‐dimensional context of nuclear organization is reflected by two well documented observations. DNA replication‐dependent histone mRNAs are synthesized at specialized subnuclear domains designated histone locus bodies (HLBs), in response to activation of the growth factor dependent Cyclin E/CDK2/HINFP/NPAT pathway at the G1/S transition in mammalian cells. Complete loss of the histone gene regulatory factors HINFP or NPAT disrupts HLB integrity that is necessary for coordinate control of DNA replication and histone gene transcription. Here we review the molecular histone‐related requirements for G1/S‐phase progression during the cell cycle. Recently developed experimental strategies, now enable us to explore mechanisms involved in dynamic control of histone gene expression in the context of the temporal (cell cycle) and spatial (HLBs) remodeling of the histone gene loci.
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
Jacob, Joseph , Bartholmai, Brian J. , Rajagopalan, Srinivasan, Moorsel, Coline H.M. van , Es, Hendrik W. van, Beek, Frouke T. van, Struik, Marjolijn H. L., Kokosi, Maria , Egashira, Ryoko , Brun, Anne‐Laure , Nair, Arjun , Walsh, Simon , Cross, Gary , Barnett, Joseph , Lauretis, Angelo De, Judge, Eoin P., Desai, Sujal R. , Karwoski, Ronald A., Ourselin, Sébastien , Renzoni, Elisabetta , Maher, Toby M. , Altmann, André , Wells, Athol U. , Karwoski, Ronald, Bartholmai, Brian J , Maher, Toby , Egashira, Ryoko

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 23, 2018 | Volume: 198 | Issue: 6 | Pages: 767-776

10.1164/rccm.201711-2174oc | PMID 29684284 Get It

Abstract Rationale Quantitative computed tomographic (CT) measures of baseline disease severity might identify patients with idiopathic pulmonary fibrosis (IPF) with an increased mortality risk. We evaluated whether quantitative CT variables could act as a cohort enrichment tool in future IPF drug trials. Objectives To determine whether computer-derived CT measures, specifically measures of pulmonary vessel–related structures (VRSs), can better predict functional decline and survival in IPF and reduce requisite sample sizes in drug trial populations. Methods Patients with IPF undergoing volumetric noncontrast CT imaging at the Royal Brompton Hospital, London, and St. Antonius Hospital, Utrecht, were examined to identify pulmonary function measures (including FVC) and visual and computer-derived (CALIPER [Computer-Aided Lung Informatics for Pathology Evaluation and Rating] software) CT features predictive of mortality and FVC decline. The discovery cohort comprised 247 consecutive patients, with validation of results conducted in a separate cohort of 284 patients, all fulfilling drug trial entry criteria. Measurements and Main Results In the discovery and validation cohorts, CALIPER-derived features, particularly VRS scores, were among the strongest predictors of survival and FVC decline. CALIPER results were accentuated in patients with less extensive disease, outperforming pulmonary function measures. When used as a cohort enrichment tool, a CALIPER VRS score greater than 4.4% of the lung was able to reduce the requisite sample size of an IPF drug trial by 26%. Conclusions Our study has validated a new quantitative CT measure in patients with IPF fulfilling drug trial entry criteria—the VRS score—that outperformed current gold standard measures of outcome. When used for cohort enrichment in an IPF drug trial setting, VRS threshold scores can reduce a required IPF drug trial population size by 25%, thereby limiting prohibitive trial costs. Importantly, VRS scores identify patients in whom antifibrotic medication prolongs life and reduces FVC decline.
P84Metabolomic profiling of human fetal cardiac mesenchymal stromal cells
Bulatović, Ivana, Vucković, I, Zhang, S, Folmes, Clifford D.L. , Österholm, Cecilia , Terzic, André , Grinnemo, Karl‐Henrik

Mayo Clinic

Cardiovascular Research | April 23, 2018 | Volume: 114 | Issue: suppl_1 | Pages: S22-S22

10.1093/cvr/cvy060.048 Get It